A detailed history of Lazard Asset Management LLC transactions in Surmodics Inc stock. As of the latest transaction made, Lazard Asset Management LLC holds 3,315 shares of SRDX stock, worth $132,633. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,315
Previous 12,930 74.36%
Holding current value
$132,633
Previous $543,000 76.43%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$38.47 - $42.24 $369,889 - $406,137
-9,615 Reduced 74.36%
3,315 $128,000
Q2 2024

Aug 14, 2024

BUY
$25.39 - $42.1 $184,102 - $305,267
7,251 Added 127.68%
12,930 $543,000
Q1 2024

May 14, 2024

BUY
$27.44 - $35.56 $18,467 - $23,931
673 Added 13.44%
5,679 $166,000
Q4 2023

Feb 14, 2024

BUY
$28.47 - $38.49 $10,249 - $13,856
360 Added 7.75%
5,006 $181,000
Q3 2023

Nov 14, 2023

BUY
$28.28 - $38.36 $131,388 - $178,220
4,646 New
4,646 $149,000
Q3 2021

Nov 15, 2021

SELL
$52.8 - $60.32 $14,256 - $16,286
-270 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$51.29 - $59.15 $13,848 - $15,970
270 New
270 $14,000
Q4 2020

Feb 11, 2021

SELL
$35.18 - $43.52 $54,247 - $67,107
-1,542 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$37.98 - $48.72 $3,114 - $3,995
-82 Reduced 5.05%
1,542 $59,000
Q2 2020

Aug 13, 2020

BUY
$31.07 - $44.74 $1,926 - $2,773
62 Added 3.97%
1,624 $70,000
Q1 2020

May 14, 2020

BUY
$22.46 - $42.24 $20,887 - $39,283
930 Added 147.15%
1,562 $52,000
Q4 2019

Feb 13, 2020

BUY
$39.01 - $47.51 $11,429 - $13,920
293 Added 86.43%
632 $26,000
Q3 2019

Nov 14, 2019

BUY
$38.66 - $47.41 $13,105 - $16,071
339 New
339 $15,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $560M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.